Literature DB >> 2671111

Insulin resistance in porphyria cutanea tarda.

F Calcinaro1, G Basta, P Lisi, C Cruciani, M Pietropaolo, F Santeusanio, A Falorni, R Calafiore.   

Abstract

It has been reported that patients with porphyria cutanea tarda (PCT) develop carbohydrate (CHO) intolerance and manifest diabetes melitus (DM) more frequently than the normal population. In order to verify whether this is due to insulin resistance we studied 5 patients with PCT and 5 normal subjects matched for age, sex and weight. In all the patients an evaluation consisted of the glycemic curve and insulin response to an iv glucose tolerance test (IVGTT: 0.33 g/kg) as well as of an evaluation of the circulating monocyte insulin receptors. Blood samples were drawn in the basal state to measure plasma levels of NEFA, glycerol, and intermediate metabolites. The patients with PCT showed normal glucose tolerance which was obtained, however, at the expense of the elevated insulin levels: therefore a condition of insulin resistance was demonstrated in these subjects. An involvement of the lipid metabolism, observed by the raised levels of plasma NEFA and glycerol, was also evident. The insulin binding to circulating monocytes was reduced but not enough to justify the degree of insulin resistance observed. Therefore, it could be hypothesized, in agreement with similar studies, that a postreceptor defect is responsible for the insulin-resistance observed in patients with PCT and that the reduction of insulin receptors is determined by the down regulation in response to elevated insulinemic levels. An alteration of the porphyrin metabolism might be responsible for this disorder.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2671111     DOI: 10.1007/BF03350708

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  32 in total

1.  Immunoassay of endogenous plasma insulin in man.

Authors:  R S YALOW; S A BERSON
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

2.  The prophyrins and the porphyrias.

Authors:  L EALES
Journal:  Annu Rev Med       Date:  1961       Impact factor: 13.739

3.  Microdetermination of long-chain fatty acids in plasma and tissues.

Authors:  V P DOLE; H MEINERTZ
Journal:  J Biol Chem       Date:  1960-09       Impact factor: 5.157

4.  Cooperativity in ligand binding: a new graphic analysis.

Authors:  P De Meyts; J Roth
Journal:  Biochem Biophys Res Commun       Date:  1975-10-27       Impact factor: 3.575

5.  [Porphyria cutanea tarda and diabetes mellitus].

Authors:  E Köstler
Journal:  Dermatol Monatsschr       Date:  1986

6.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

Review 7.  New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus.

Authors:  R A DeFronzo; E Ferrannini; V Koivisto
Journal:  Am J Med       Date:  1983-01-17       Impact factor: 4.965

8.  Abnormalities of growth hormone regulation in acute intermittent porphyria.

Authors:  M G Perlroth; D P Tschudy; A Waxman; W D Odell
Journal:  Metabolism       Date:  1967-01       Impact factor: 8.694

9.  Extreme insulin resistance in ataxia telangiectasia: defect in affinity of insulin receptors.

Authors:  R S Bar; W R Levis; M M Rechler; L C Harrison; C Siebert; J Podskalny; J Roth; M Muggeo
Journal:  N Engl J Med       Date:  1978-05-25       Impact factor: 91.245

10.  Insulin resistance in liver cirrhosis: decreased insulin binding to circulating monocytes.

Authors:  A V Greco; A Bertoli; G Ghirlanda; R Manna; L Altomonte; A G Rebuzzi
Journal:  Horm Metab Res       Date:  1980-11       Impact factor: 2.936

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.